Techniques: Synthetic biology-based protocol to differentiate human induced pluripotent stem (iPS) cell-derived pancreatic progenitors into mature β-like cells

Drug platforms

TECHNOLOGY: Cell therapy

A synthetic lineage-control network could program human iPS cell-derived pancreatic progenitor cells into mature

Read the full 173 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE